Now Trending: Working Americans Concerned About Future of Medicine, FDA Panel Rejects MDMA

News
Slideshow

Check out this recap of articles published on our sister sites during the past week.

Explore articles from the past week published on Drug Topics’ sister brands AJMC, Formulary Watch, and Managed Healthcare Executive. From the FDA denying approval for MDMA to the prominence of mental health care in telehealth environments, read up on recent health care industry news.

READ MORE: Weekend ICYMI: May 27 to May 31

Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips? Sign up today for our free Drug Topics newsletter.

Related Content
Medication, Health Care Affordability Improved During COVID-19 Pandemic

Medication, Health Care Affordability Improved During COVID-19 Pandemic

Brian Nowosielski
July 15th 2024
Article

Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.

GLP-1s, SGLT2 Inhibitors Reduce Progression of CKD

GLP-1s, SGLT2 Inhibitors Reduce Progression of CKD

Brian Nowosielski
June 14th 2024
Article

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

Financial Incentives Show Significant Success for Weight Loss in Men

Financial Incentives Show Significant Success for Weight Loss in Men

Brian Nowosielski
May 22nd 2024
Article

Researchers analyzed groups of men given financial incentives to motivate weight-loss behaviors compared with a non-incentivized control group.

FDA Approves Updated Label for Altuviiio for Effective Bleed Protection in Children Younger than 12 Years

FDA Approves Updated Label for Altuviiio for Effective Bleed Protection in Children Younger than 12 Years

Lauren Biscaldi, MS, Managing Editor
May 13th 2024
Article

Altuviiio was first granted approval by the FDA in February 2023.

Pharmacogenetic Testing Recommendations Needed in Clinical Guidelines to Increase Consistency

Pharmacogenetic Testing Recommendations Needed in Clinical Guidelines to Increase Consistency

Killian Meara
May 2nd 2024
Article

A review found that many guidelines that recommended pharmacogenetic testing were inconsistent between clinical associations.

Leqvio Gets Label Update For Earlier Use in Patients with Heart Disease

Leqvio Gets Label Update For Earlier Use in Patients with Heart Disease

Formulary Watch Staff
July 12th 2023
Article

Recent safety data also allowed four adverse events to be removed from the label.

© 2024 MJH Life Sciences

All rights reserved.